Cameron J S
Renal Unit, Clinical Science Laboratories, Guy's Hospital, London, UK.
Pediatr Nephrol. 1990 Mar;4(2):193-8. doi: 10.1007/BF00858840.
Membranous nephropathy is predominantly a disease of middle-aged and elderly individuals, and is thus rather an uncommon finding in proteinuric and nephrotic children. In children, it differs in several important respects from the disease as seen in adults: an apparent associated cause is more common, macroscopic haematuria is seen quite frequently, a relapsing course is more often noted, renal venous thrombosis is not found and evolution into renal failure is the exception. Nevertheless, a proportion of children with membranous nephropathy do evolve into renal failure, and their management is discussed with particular reference to recent papers on the treatment of membranous nephropathy in adults. An aggressive search for associated disease is worthwhile in children, and one should wait to see what the evolution or proteinuria and renal function may be. If a progressive course becomes evident, then a trial of treatment with corticosteroids is worthwhile, but if this is ineffective then a more aggressive approach involving the use of alkylating agents may be justified. It remains undetermined what the best regime in children and adolescents may be.
膜性肾病主要是一种中老年疾病,因此在蛋白尿和肾病患儿中是一种相当罕见的病症。在儿童中,它在几个重要方面与成人所患的该疾病有所不同:明显的相关病因更为常见,肉眼血尿相当频繁地出现,复发病程更为常见,未发现肾静脉血栓形成,演变为肾衰竭只是个别情况。然而,一部分患有膜性肾病的儿童确实会发展为肾衰竭,本文将结合近期关于成人膜性肾病治疗的论文,特别讨论对他们的管理。对儿童进行积极的相关疾病筛查是值得的,而且应该等待观察蛋白尿和肾功能的演变情况。如果病情进展明显,那么试用皮质类固醇进行治疗是值得的,但如果无效,那么采用更积极的使用烷化剂的方法可能是合理的。儿童和青少年的最佳治疗方案仍未确定。